USPTO serial 97561121
NTH BIOLOGY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DIBLE, JONATHON I
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NTH BIOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DAVID R. CONKLIN
DAVID R. CONKLIN KIRTON MCCONKIE301 N. 200 EASTSUITE 3AST. GEORGE, UT 84770Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom manufacturing of recombinant constituents to the order and specification of others, namely, manufacturing of recombinant proteins, recombinant antibodies, recombinant polymers, recombinant biopolymers, recombinant vaccines, recombinant lipids, and recombinant enzymes; microbial fermentation services in the nature of custom manufacturing of recombinant constituents, namely, recombinant proteins, recombinant antibodies, recombinant polymers, recombinant biopolymers, recombinant vaccines, recombinant lipids, and recombinant enzymes; contract manufacturing services of recombinant constituents to the order and specification of others, namely, manufacturing of recombinant proteins, recombinant antibodies, recombinant polymers, recombinant biopolymers, recombinant vaccines, recombinant lipids, and recombinant enzymes; custom manufacturing of human foodstuffs additives and of human nutrition in the nature of recombinant constituents, namely, recombinant proteins, recombinant antibodies, recombinant polymers, recombinant biopolymers, recombinant vaccines, recombinant lipids, and recombinant enzymes; manufacturing services for others in the field of proteins, peptides, amino acids, biochemicals, biopolymers, lipids, oils, fatty acids, flavors, fragrances, nutritional supplements, and food ingredients; custom manufacturing of products, ingredients, and additives, namely, vitamins, minerals, amino acids, proteins, and enzymes, all for use in the food, agriculture, pharmaceutical, biologics, textile, and personal care industries; manufacturing process consulting; custom additive manufacturing of recombinant constituents through custom synthesizing and blending of ingredients, namely, manufacturing of recombinant proteins, recombinant antibodies, recombinant polymers, recombinant biopolymers, recombinant vaccines, recombinant lipids, and recombinant enzymes, all in the fields of food, agriculture, pharmaceutical, biologics, textile, and personal care products for others | ACTIVE | — |
| 042 | Technical researching in the field of manufacturing processes; research and development for others in the field of manufacturing processes for sustainable food, agriculture, pharmaceuticals, biologic medical products, textiles, and personal care products utilizing recombinant constituents, namely, recombinant proteins, recombinant antibodies, recombinant polymers, recombinant biopolymers, recombinant vaccines, recombinant lipids, and recombinant enzymes; technical consulting services in the fields of biochemistry and biotechnology relating to food, agriculture, pharmaceuticals, biologic medical products, textiles, and personal care products utilizing recombinant constituents, namely, recombinant proteins, recombinant antibodies, recombinant polymers, recombinant biopolymers, recombinant vaccines, recombinant lipids, and recombinant enzymes; biotechnological research and development; natural science services, namely, technical consultation, research, product development, custom design of prototypes, providing information, design and development of engineering processes for product manufacturing, and quality control of goods and services, all in the field of natural science; consultancy in the field of biotechnology; providing information relating to scientific research in the field of biochemistry and biotechnology; research and development in the field of biotechnology; research and development of new products for others; design and development of recombinant constituents, namely, recombinant proteins, recombinant antibodies, recombinant polymers, recombinant biopolymers, recombinant vaccines, recombinant lipids, and recombinant enzymes, all in the fields of food, agriculture, pharmaceutical, biologics, textile, and personal care; design and development of engineering processes for product manufacturing in the fields of food, agriculture, pharmaceutical, biologics, textile, and personal care; providing information in the field of biochemistry relating to biochemical characterization, analysis methods, and uses of recombinant constituents, all for scientific and medical research purposes, and for purposes of design and development of sustainable new products for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 6, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 6, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 4, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 1, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 1, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 4, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 4, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 4, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 5, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 26, 2022 | NWAP | NEW APPLICATION ENTERED | — |